News

Key Takeaways Period-driven inflammation could influence the risk of pain events among women with sickle cell diseaseLevels ...
Meet the low-cost standard for hypoxic and physioxic environment cell culture that enabled HIF-1α Nobel Prize-winning research. Lab safety rules dictate that one must tie back long hair. Rosemarie ...
The potential target, the FLT1 gene, contributes to the production of a protein, fetal hemoglobin, whose presence is already known to improve the lifespan of people with sickle cell disease.
A New York hospital has declared a patient cured of sickle-cell anemia, a debilitating genetic disorder that mostly affects individuals of African heritage. Considered to be cured, other genetic ...
Doctors at Northwell Health in New York used stem cell therapy Lyfgenia to cure sickle cell anemia for the first time. HealthDay News — For 21 years, Sebastien Beauzile lived with the chronic pain of ...
The hospital used an advanced therapy called Lyfgenia, which modifies a patient's own bone marrow to produce healthy red blood cells. HealthDay News — For 21 years, Sebastien Beauzile lived with ...
Sickle cell is a blood disorder where the body creates mutated red blood cell proteins. It often leads to pain, anemia and other issues. The National Institute of Health says it touches more than ...
MONDAY, March 17, 2025 (HealthDay News) — For 21 years, Sebastien Beauzile lived with the chronic pain of sickle cell anemia. Now, thanks to a groundbreaking genetic treatment, he is the first person ...
MONDAY, March 17, 2025 (HealthDay News) -- For 21 years, Sebastien Beauzile lived with the chronic pain of sickle cell anemia. Now, thanks to a groundbreaking genetic treatment, he is the first ...
For 21 years, Sebastien Beauzile lived with the chronic pain of sickle cell anemia. Now, thanks to a groundbreaking genetic treatment, he is the first person in New York to be cured of the disease.